![]() |
Volumn 12, Issue 4, 2016, Pages 451-452
|
The Cobas® EGFR Mutation Test v2 assay
|
Author keywords
Cobas EGFR Mutation Test v2; in vitro diagnostics; lung cancer; oncology
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
ANTINEOPLASTIC AGENT;
DIAGNOSTIC KIT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
PROTEIN KINASE INHIBITOR;
CANCER DIAGNOSIS;
CANCER PATIENT;
COBAS EGFR MUTATION TEST V2;
COMMERCIAL PHENOMENA;
GENE MUTATION;
GENETIC SCREENING;
HUMAN;
LIQUID BIOPSY;
MOLECULAR DIAGNOSTICS;
MOLECULAR GENETICS;
NON SMALL CELL LUNG CANCER;
NOTE;
PATIENT SELECTION;
PRIORITY JOURNAL;
TUMOR BIOPSY;
ANTAGONISTS AND INHIBITORS;
CARCINOMA, NON-SMALL-CELL LUNG;
DIAGNOSTIC KIT;
GENETICS;
INTERVIEW;
LUNG NEOPLASMS;
MOLECULARLY TARGETED THERAPY;
MUTATION;
PROCEDURES;
RESEARCH;
STANDARDS;
SUPPLY AND DISTRIBUTION;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
GENETIC TESTING;
HUMANS;
LUNG NEOPLASMS;
MOLECULAR TARGETED THERAPY;
MUTATION;
PATIENT SELECTION;
PROTEIN KINASE INHIBITORS;
REAGENT KITS, DIAGNOSTIC;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RESEARCH;
|
EID: 84957684205
PISSN: 14796694
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/fon.15.311 Document Type: Note |
Times cited : (40)
|
References (0)
|